protein typically better job standard chemotherapy slowing disease patients normal genes tumors not benefit anti- drugs routine genetic tests helped people melanoma form skin cancer half patients melanoma mutation gene plays role spread cancer tumor parts body 2011 fda approved drug inhibits mutant braf protein recent study found nearly 80 patients metastatic melanoma responded new treatment lived average years longer 5.3 months typically seen patients skin cancer spread particular mutation allows doctors steer clear prescribing certain drugs example colorectal cancers mutations gene typically not respond particular medicines genetic changes render agents ineffective obstacles progress finding genetic abnormality cancer not aberration